Comparison results
Results: Differences Similar | ✘H25-H28 | ✘Transient blindness | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||
Register, to see more distinctive signs of diseases and studies | 39% | 85% | |||||||
cataract | 88% | — | |||||||
transient blindness | — | 43% | |||||||
s eyes cloudy | 83% | — | |||||||
retinal angiospasm | — | 42% | |||||||
initial cataract | 73% | — | |||||||
giant cell arteritis | — | 36% | |||||||
eye injury | 65% | — | |||||||
rheumatic polymyalgia | — | 34% | |||||||
senile hyperopia | 59% | — | |||||||
fundus arteries narrowed | — | 33% | |||||||
tension in the eyes | 56% | — | |||||||
rheumatic muscle pain | — | 33% | |||||||
worse in the fog | 53% | — | |||||||
nausea | — | 31% | |||||||
secondary cataract | 53% | — | |||||||
photopsia | — | 30% | |||||||
congenital cataract | 51% | — | |||||||
systemic vasculitis | — | 29% | |||||||
gray eyes | 51% | — | |||||||
vascular spasm | — | 28% | |||||||
calm person | 51% | — | |||||||
thrombosis | — | 27% | |||||||
hyperopia | 50% | — | |||||||
numbness of the scalp | — | 27% | |||||||
more often in old age | 46% | — | |||||||
rheumatic inflammation | — | 27% | |||||||
deterioration of vision | 45% | — | |||||||
vitamin b3 increased | — | 27% | |||||||
shroud | 45% | — | |||||||
dilated pupils | — | 27% | |||||||
immaturity | 42% | — | |||||||
arterial occlusion | — | 26% | |||||||
liebman-sachs endocarditis | 41% | — | |||||||
rheumatism | — | 26% | |||||||
endocarditis | 40% | — | |||||||
angiopathy of the retina | — | 25% | |||||||
head injury | 39% | — | |||||||
vasculitis | — | 25% | |||||||
injury | 53% | 15% | |||||||
impaired arterial function | — | 24% | |||||||
does not feel pain | 36% | — | |||||||
spasm | — | 24% | |||||||
fighting | 35% | — | |||||||
eye spasm | — | 23% | |||||||
diabetes mellitus | 34% | — | |||||||
hypertrophy of the nasal conchae | — | 23% | |||||||
impaired lung function | 32% | — | |||||||
better lying | — | 22% | |||||||
consequences of taking medications | 51% | 18% | |||||||
angiopathy | — | 22% | |||||||
eye surgery | 56% | 24% | |||||||
limitation of the mobility of the eyeballs | — | 22% | |||||||
myopia | 44% | 15% | |||||||
muscle pain | — | 22% | |||||||
consequences of operation | 45% | 16% | |||||||
numbness in the head | — | 21% | |||||||
visual impairment | 51% | 22% | |||||||
it gets dark in the eyes | — | 19% | |||||||
blurred vision | 39% | 14% | |||||||
pupils enlarged | — | 19% | |||||||
heart dysfunction | 32% | 22% | |||||||
hematoma | — | 19% | |||||||
inflammation | 29% | 20% | |||||||
traumatic illness | — | 18% | |||||||
insensitivity to pain | 34% | 26% | |||||||
defects of the upper jaw | — | 18% | |||||||
numbness of the skin | — | 18% | |||||||
occlusion of the central retinal vein | — | 18% | |||||||
ptosis of the upper eyelids | — | 17% | |||||||
changes in the blood | — | 17% | |||||||
pain in the eye sockets | — | 16% | |||||||
acute pain | — | 16% | |||||||
neurological disorders | — | 16% | |||||||
eye sensitivity | — | 15% | |||||||
blood diseases | — | 15% | |||||||
nose large eyes | — | 15% | |||||||
acceleration of movements | — | 15% | |||||||
nerve damage | — | 15% | |||||||
violation of fat metabolism | — | 15% | |||||||
peripheral artery thrombosis | — | 15% | |||||||
skin problems | — | 15% | |||||||
lipid metabolism | — | 14% | |||||||
speech slurred | — | 13% | |||||||
pain in the eyes | — | 13% | |||||||
constantly moving | — | 13% | |||||||
control issues | — | 12% | |||||||
IBS | — | 12% | |||||||
skin sensations | — | 12% | |||||||
subacute condition | — | 12% | |||||||
sensations in the head | — | 12% | |||||||
wound | — | 12% | |||||||
allergy | — | 11% | |||||||
patient behavior | — | 11% | |||||||
up circulatory disorders | — | 11% | |||||||
swelling | — | 11% | |||||||
double vision | 43% | 52% |
Instructions
Video
|